The global seasonal influenza vaccines market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factor that is expected to fuel the growth of the market includes an increase in the prevalence of influenza epidemics and seasonal outbreaks. The viral infection which occurs due to flu in the respiratory system is called influenza. The influenza virus travels through respiratory droplets and is contagious. It can also spread from one person to another while talking or due to physical contact.
Additionally, the influenza virus circulates continuously, causing regional epidemics and outbreaks which leads to thousands of mortalities. The changing character of the virus is compelling an annual change in the vaccine strain to match the influenza virus strain. Healthcare organizations globally such as the Centers for Disease Control and Prevention (CDC) have suggested vaccines like baloxavir marboxil (Xofluza) for the treatment of influenza symptoms in patients.
To Request a Sample of our Report on Global Seasonal Influenza Vaccines Market: https://www.omrglobal.com/request-sample/seasonal-influenza-vaccines-market
The vaccines used for influenza are made up of three different influenza viruses like influenza type A with H3N2 virus strain, influenza type A with H1N1 virus strain, and influenza type B virus strain. Moreover, an increase in government support and surveillance regarding vaccination against influenza on the national and global levels to monitor the supply, distribution, and administration of flu vaccines is one of the major factors driving the market growth. In addition, an increase in investment by leading market players across the globe and a rise in government funding has facilitated the launch of therapeutically effective vaccines, which is another factor that is expected to augment the growth of the market during the forecast period.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segment Covered
- Regions Covered- Globally
Competitive Landscape: AstraZeneca plc, CSL Ltd., Emergent BioSolutions Inc., and F. Hoffmann-La Roche AG., among others.
A full Report of Global Seasonal Influenza Vaccines Market is Available @ https://www.omrglobal.com/industry-reports/seasonal-influenza-vaccines-market
Global Seasonal Influenza Vaccines Market Report by Segment
By Type
- Quadrivalent
- Trivalent
By Virus Type
- Influenza Virus Type A
- Influenza Virus Type B
By Age Group
- Pediatric
- Adult
Global Seasonal Influenza Vaccines Market by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/seasonal-influenza-vaccines-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
